- Home
- ACDC vs ARDX Comparison
ACDC vs ARDX Comparison
Compare ACDC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- ARDX
- Stock Information
- Founded
- ACDC 2014
- ARDX 2007
- Country
- ACDC United States
- ARDX United States
- Employees
- ACDC N/A
- ARDX N/A
- Industry
- ACDC Oilfield Services/Equipment
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- ACDC Energy
- ARDX Health Care
- Exchange
- ACDC Nasdaq
- ARDX Nasdaq
- Market Cap
- ACDC 1.1B
- ARDX 1.3B
- IPO Year
- ACDC 2022
- ARDX 2014
- Fundamental
- Price
- ACDC $7.59
- ARDX $4.91
- Analyst Decision
- ACDC Hold
- ARDX Strong Buy
- Analyst Count
- ACDC 5
- ARDX 9
- Target Price
- ACDC $7.60
- ARDX $10.61
- AVG Volume (30 Days)
- ACDC 516.1K
- ARDX 3.8M
- Earning Date
- ACDC 03-06-2025
- ARDX 05-01-2025
- Dividend Yield
- ACDC N/A
- ARDX N/A
- EPS Growth
- ACDC N/A
- ARDX N/A
- EPS
- ACDC N/A
- ARDX N/A
- Revenue
- ACDC $2,190,900,000.00
- ARDX $333,615,000.00
- Revenue This Year
- ACDC N/A
- ARDX $14.26
- Revenue Next Year
- ACDC $12.88
- ARDX $32.49
- P/E Ratio
- ACDC N/A
- ARDX N/A
- Revenue Growth
- ACDC N/A
- ARDX 168.06
- 52 Week Low
- ACDC $5.16
- ARDX $4.32
- 52 Week High
- ACDC $9.75
- ARDX $9.33
- Technical
- Relative Strength Index (RSI)
- ACDC 50.89
- ARDX 39.95
- Support Level
- ACDC $6.90
- ARDX $5.00
- Resistance Level
- ACDC $8.29
- ARDX $5.56
- Average True Range (ATR)
- ACDC 0.44
- ARDX 0.26
- MACD
- ACDC 0.06
- ARDX -0.05
- Stochastic Oscillator
- ACDC 49.82
- ARDX 22.27
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.